RLMD
USDRelmada Therapeutics Inc. Common Stock
$2.770+0.560 (25.339%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.210
High
$2.810
Low
$2.190
Volume
0.98M
Company Fundamentals
Market Cap
91.9M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.74M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.24Current $2.770High $3.5
Related News
GlobeNewswire
Relmada Therapeutics Announces Pricing of $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
CORAL GABLES, Fla., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (NASDAQ:RLMD, "Relmada" or the "Company")), a clinical-stage biotechnology company advancing innovative therapies for oncology and
View more
GlobeNewswire
Relmada Announces FDA Feedback Supporting 2 Separate Acceptable Registrational Study Paths for NDV-01 in Non-muscle Invasive Bladder Cancer
Announces NDV-01 9-Month Follow-up Safety and Efficacy Data in NMIBC FDA feedback supports 2 potential registrational trials – 1) a registrational trial in 2nd line refractory BCG-unresponsive NMIBC, and 2) a randomized
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.